Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph not_applicable
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Completed(1)

Detailed Status

Recruiting2
Completed1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

completed125%
recruiting250%
enrolling_by_invitation125%

Recent Activity

2 active trials
Showing 4 of 4
recruiting

Pediatric PET/MR Image Registry

NCT03458520
recruitingphase_1

Assess Fibrin in Brains With AD/ADRD

NCT05336695
completed

Somatotopy in Parkinson's Disease

NCT04876404
enrolling_by_invitationnot_applicable

Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment.

NCT03514524

Clinical Trials (4)

Showing 4 of 4 trials
NCT03458520

Pediatric PET/MR Image Registry

Recruiting
NCT05336695Phase 1

Assess Fibrin in Brains With AD/ADRD

Recruiting
NCT04876404

Somatotopy in Parkinson's Disease

Completed
NCT03514524Not Applicable

Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment.

Enrolling By Invitation

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4